Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 535-546

  Cai, Zhenzi ^a   Stancou, Rodica ^a   Körner, Marie ^b   Chouaib, Salem ^a,c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FAS ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR; VINBLASTINE; VINCRISTINE;

ARTICLE; BREAST CARCINOMA; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG RESISTANCE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD95; DOXORUBICIN; DRUG RESISTANCE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HUMANS; INTERFERON TYPE II; P-GLYCOPROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VINBLASTINE; VINCRISTINE;

EID: 0029847356     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<535::AID-IJC21>3.0.CO;2-2     Document Type: Article

References (23)

1. ARASE, H., ARASE, N. and SAITO, T., Fas-mediated cytotoxicity by freshly isolated natural-killer cells. J. exp. Med., 181, 1235-1238 (1995).
2. BECK, W.T., MUELLER, T.J. and TANZER, L.R., Altered surface-membrane glycoproleins in vinca-alkaloid-resistant human leukemic lymphoblasts. Cancer Res., 39, 2070-2076 (1979).
3. BÉNARD, J., SILVA, J.D., TEYSSIER, J. and RIOU, G., Over-expression of MDR1 gene with no DMA amplification in a multiple-drug-resistant human ovarian-carcinoma cell line. Int. J. Cancer, 43, 471-477 (1989).
4. CHENG, J., ZHOU, T., LIU, C., SHAPIRO, J.P., BRAUER, M.J., KIEFER, M.C., BARR, P.J. and MOUNTZ, J.D., Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science, 263, 1759-1762 (1994).
5. CHOUAIB, S., ROBINET, E., ZYAD, A. and BRANELLEC, D., The tumor necrosis factor α: pleiotropic cytokine. Bull. Cancer, 79, 935-949 (1992).
6. FAIRCHILD, C.R., IVY, S.P., KAO-SHANG, C.S., WHANG-PENG, J., ROSEN, N., ISRAEL, M.A., MELERA, P.W., COWAN, K.H. and GOLDSMITH, M.E., Isolation of amplified and over-expressed DNA sequences from adriamycin-resistant human breast-cancer cells. Cancer Res., 47, 5141-5148 (1987).
7. FRIESEN, C., HERR, I., KRAMMER, P. and DEBATIN, K.-M., Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Medicine, 2, 574-577 (1996).
8. GOTTESMAN, M.M., GOLDSTEIN, L.J., FOJO, A., GALSKI, H. and PASTAN, I., Expression of the multidrug-resistance gene in human cancer. In: I.B. Ronison (ed.), Molecular and cellular biology of multidrug resistance in tumor cells, pp. 291-301, Plenum Press, New York (1991).
9. HANABUCHI. S., KOYANAGI, M., KAWASAKI, A., SHINOHARA, N., MATSUZAWA, A., NISHIMURA, Y., KOBAYASHI, Y., YONEHARA, S., YAGITA, H. and OKUMURA, K., Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. nat. Acad. Sci. (Wash.). 91, 4930-4934 (1994).
10. HARRISON, D.J., Molecular mechanisms of drug resistance in tumours. J. Pathol., 175, 7-12 (1995).
11. HICKMAN, J.A., Apoptosis induced by anti-cancer drugs. Cancer Metastasis Re., 11, 121-139 (1992).
12. ITOH, N., YONEHARA, S., ISHII, A., YONEHARA, M., MIZUSHIMA, S., SAMESHIMA, M., HASE, A., SETO, Y. and NAGATA, S., The polypeptide encoded by the cDNA for human cell-surface antigen Fas can mediate apoptosis. Cell, 66, 233-243 (1991).
13. LEBEL, M., BERTRAND, R. and MES-MASSON, A.M., Decreased Fasantigen-receptor expression in testicular-tumor cell lines derived from polyomavirus-large-T antigen transgenic mice. Oncogene, 12, 1127-1135 (1996).
14. LEJEUNE, F., LIENARD, D., EGGERMONT, A., SCHRAFFORDT, K.H., KROON, B., GERAIN, J., ROSENKAIMER, F. and SCHMITZ, P., Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. Circulatory Shock, 43, 191-197 (1994).
15. MCCLEAN, S. and HULL, B.T., An overview of membrane, cytosolic and nuclear proteins associated with the expression of resistance to multiple drugs in vitro. Biochem. biophys. Acta, 1114, 107-127 (1992).
16. NAGATA, S. and GOLSTEIN, P., The Fas death factor. Science, 267, 1449-1456 (1995).
17. NATOLI, G., IANNI, A., COSTANZO, A., PETRILLO, G.D., ILARI, I., CHIRILLO, P., BALSANO, C. and LEVRERO, M., Resistance to Fasmediated apoptosis in human hepatoma cells. Oncogene, 11, 1157-1164 (1995).
18. OWEN-SCHAUB, L.B., ZHANG, W., CUSACK, J.C., ANGELO, L.S., SANTEE, S.M., FUJIMARA, T., ROTH, J.A., DEISSEROTH, A.B., ZHANG, W., KRUZEL, E. and RADINSKY, R., Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. cell. Biol., 15, 3032-3040 (1995).
19. PASTAN, I. and GOTTESMAN, M., Multidrug resistance in human cancer. New Engl. J. Med., 316, 1388-1393 (1987).
20. SUDA, T. and NAGATA, S., Purification and characterization of the Fas ligand that induces apoptosis. J. exp. Med., 179, 873-879 (1994).
21. TARTAGLIA, L.A., AYRES, T.M., WONG, G.H.W. and GOEDDEL, D.V., A novel domain within the 55-kd TNF receptor signals cell death. Cell, 74, 845-853 (1993).
22. ZÖRNIG, M., GRZESCHICZEK, A., KOWALSKI, M.B., HARTMANN, K.U. and MÖRÖY, T., Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in Eμ L-myc transgenic mice but not in animals infected with MoMuLV. Oncogene, 10, 2397-2401 (1995).
23. ZYAD, A., BÉNARD, J., TURSZ, T., CLARKE, R. and CHOUAIB, S., Resistance to TNF-α and adriamycin in the human breast-cancer MCF-7 cell line: relationship to MDR1, MnSOD and TNF gene expression. Cancer Res., 54, 825-831 (1994).